体位性頻脈症候群（POTS）治療の世界市場（～2026年）

• 英文タイトル：Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04336
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は体位性頻脈症候群（POTS）治療のグローバル市場について調査・分析したレポートです。種類別（一次フォーム、二次フォーム）市場規模、用途別（病院、診療所、外来外科センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別体位性頻脈症候群（POTS）治療の競争状況、市場シェア
・世界の体位性頻脈症候群（POTS）治療市場：種類別市場規模 2015年-2020年（一次フォーム、二次フォーム）
・世界の体位性頻脈症候群（POTS）治療市場：種類別市場規模予測 2021年-2026年（一次フォーム、二次フォーム）
・世界の体位性頻脈症候群（POTS）治療市場：用途別市場規模 2015年-2020年（病院、診療所、外来外科センター、研究所）
・世界の体位性頻脈症候群（POTS）治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、外来外科センター、研究所）
・北米の体位性頻脈症候群（POTS）治療市場分析：米国、カナダ
・ヨーロッパの体位性頻脈症候群（POTS）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの体位性頻脈症候群（POTS）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の体位性頻脈症候群（POTS）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの体位性頻脈症候群（POTS）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Novartis、AstraZeneca、Merck、Sanofi、Daiichi Sankyo、Bayer
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from lying to standing causes an abnormally large increase in heart rate.
Postural orthostatic tachycardia syndrome treatment may include avoiding factors that bring on symptoms, increasing dietary salt and water, compression stockings, exercise, cognitive behavioral therapy and medications.

Market Analysis and Insights: Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
The global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Scope and Market Size
Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Novartis
AstraZeneca
Merck
Sanofi
Daiichi Sankyo
Bayer
…

Market segment by Type, the product can be split into
Primary Forms
Secondary Forms
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Research Institutes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue
1.4 Market by Type
1.4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Primary Forms
1.4.3 Secondary Forms
1.5 Market by Application
1.5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Perspective (2015-2026)
2.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Growth Trends by Regions
2.2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Market Size
3.1.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue (2015-2020)
3.1.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio
3.2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2019
3.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players Head office and Area Served
3.4 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service
3.5 Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)
5.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
6.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in North America (2019-2020)
6.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
6.4 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
7.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Europe (2019-2020)
7.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
7.4 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
8.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in China (2019-2020)
8.3 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
8.4 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
9.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Japan (2019-2020)
9.3 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
9.4 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
10.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
11.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in India (2019-2020)
11.3 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
11.4 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020)
12.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.1.4 Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.2.4 Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.3.4 AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.4.4 Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.5.4 Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Daiichi Sankyo
13.6.1 Daiichi Sankyo Company Details
13.6.2 Daiichi Sankyo Business Overview
13.6.3 Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.6.4 Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)
13.6.5 Daiichi Sankyo Recent Development
13.7 Bayer
13.7.1 Bayer Company Details
13.7.2 Bayer Business Overview
13.7.3 Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
13.7.4 Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)
13.7.5 Bayer Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue
Table 3. Ranking of Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Primary Forms
Table 6. Key Players of Secondary Forms
Table 7. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2015-2020)
Table 11. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players
Table 18. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players (2015-2020)
Table 20. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2019)
Table 21. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service
Table 24. Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Type (2015-2020)
Table 28. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2015-2020)
Table 30. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 34. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 36. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 40. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 42. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 46. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 48. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 52. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 54. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 58. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 64. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 66. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020)
Table 70. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Product
Table 87. AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 88. AstraZeneca Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Daiichi Sankyo Company Details
Table 100. Daiichi Sankyo Business Overview
Table 101. Daiichi Sankyo Product
Table 102. Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 103. Daiichi Sankyo Recent Development
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Product
Table 107. Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$)
Table 108. Bayer Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Primary Forms Features
Figure 3. Secondary Forms Features
Figure 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Report Years Considered
Figure 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players in 2019
Figure 15. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2019
Figure 17. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年）

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11343 2020年11月25日 92Pages
当調査資料は化学療法薬誘発性肢端紅斑（手足症候群）治療のグローバル市場について調査・分析したレポートです。種類別（鎮痛剤、抗炎症剤・抗浮腫剤、抗ヒスタミン剤、NSAID、経口/局所グルココルチコイド、ピリドキシン（ビタミンB6）、その他）市場規模、用途別（薬局・ドラッグストア、病院薬局、オンラインド...

起立性低血圧の世界市場（～2026年）

Global Orthostatic Hypotension Market Size, Status and Forecast 2020-2026
MRC2-11QY04109 2020年11月20日 93Pages
当調査資料は起立性低血圧のグローバル市場について調査・分析したレポートです。種類別（心電図、血液検査、ストレステスト、心エコー図）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）

Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY10928 2020年11月25日 94Pages
当調査資料は自閉症スペクトラム障害（ASD）治療のグローバル市場について調査・分析したレポートです。種類別（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

ドラベ症候群治療の世界市場（～2026年）

Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11711 2020年11月25日 97Pages
当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

バーター症候群治療の世界市場（～2026年）

Global Bartter Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11022 2020年11月25日 96Pages
当調査資料はバーター症候群治療のグローバル市場について調査・分析したレポートです。種類別（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬...

クッシング症候群治療の世界市場（～2026年）

Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11542 2020年11月25日 96Pages
当調査資料はクッシング症候群治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

多嚢胞性卵巣症候群治療の世界市場（～2026年）

Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04319 2020年11月20日 98Pages
当調査資料は多嚢胞性卵巣症候群治療のグローバル市場について調査・分析したレポートです。種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤）市場規模、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）市場規模、...

慢性疲労症候群治療の世界市場（～2026年）

Global Chronic Fatigue Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11362 2020年11月25日 99Pages
当調査資料は慢性疲労症候群治療のグローバル市場について調査・分析したレポートです。種類別（免疫増強剤・抗ウイルス剤、睡眠増強、CNS（中枢神経系）刺激剤）市場規模、用途別（病院、クリニック、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

発作性上室頻拍の世界市場（～2026年）

Global Paroxysmal Supraventricular Tachycardia Market Size, Status and Forecast 2020-2026
MRC2-11QY04166 2020年11月20日 91Pages
当調査資料は発作性上室頻拍のグローバル市場について調査・分析したレポートです。種類別（電気生理学的研究（EPS）、ストレステスト、心臓カテーテル検査、冠動脈造影、心電図（ECG）、心エコー検査、ホルターモニター、イベントモニター、埋め込み型モニター、ラボテスト）市場規模、用途別（病院・診療所、診断セ...

クッシング症候群・先端巨大症治療の世界市場（～2026年）

Global Cushing's Syndrome and Acromegaly Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11541 2020年11月25日 92Pages
当調査資料はクッシング症候群・先端巨大症治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

電気シチューポットの世界市場（～2026年） Market Analysis and Insights: Global Electric Stew Pots Market The global Electric Stew Pots market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Electric Stew Pots Scope and Market Size Electric Stew Pots market is segment…
起立性低血圧の世界市場（～2026年） Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine p…
ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …
慢性疲労症候群治療の世界市場（～2026年） Chronic fatigue syndrome is not a simple problem for any individual, it’s a complex disorder which is considered as thrilling fatigue, which cannot be able to explain by medical conditions. Chronic fatigue syndrome which can prime to deterioration of creatively suffering and harm of quality of life,…
バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…